Acadian Asset Management’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Acadian Asset Management’s Portfolio ETTX Stock Details ETTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-55,813	Closed	-$120K	–	1887
2021 Q4	$120K	Buy	55,813 +35,297	+172%	+$95.4K	﹤0.01%	1340
2021 Q3	$68K	Sell	20,516 -11,277	-35%	-$30.6K	﹤0.01%	1515
2021 Q2	$84K	Buy	+31,793	New	+$71.8K	﹤0.01%	1679
2020 Q4	–	Sell	-8,029	Closed	-$16K	–	2399
2020 Q3	$16K	Buy	8,029 +5,116	+176%	+$14.6K	﹤0.01%	2103
2020 Q2	$9K	Hold	2,913	–	–	﹤0.01%	2177
2020 Q1	$8K	Hold	2,913	–	–	﹤0.01%	1720
2019 Q4	$14K	Hold	2,913	–	–	﹤0.01%	1744
2019 Q3	$17K	Hold	2,913	–	–	﹤0.01%	1735
2019 Q2	$19K	Buy	+2,913	New	+$18.7K	﹤0.01%	1611

Other funds holding ETTX

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

DMKJ

David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return

Acadian Asset Management's ETTX Position: Q1 2022 in Review

Acadian Asset Management sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q1 2022, closing a stake of 55,813 shares — an estimated $120K sold.

Acadian Asset Management first reported a position in ETTX in Q2 2019 and held it in 9 quarters. The position peaked at $120K in Q4 2021. 22 funds tracked by Wall St. Rank hold ETTX as of Q1 2022.

Acadian Asset Management reported no remaining Entasis Therapeutics Holdings Inc. position as of Q1 2022 after selling out during the quarter.
Acadian Asset Management sold 55,813 Entasis Therapeutics Holdings Inc. shares in Q1 2022, an estimated $120K.
Acadian Asset Management first reported a position in Entasis Therapeutics Holdings Inc. in Q2 2019 and held it in 9 quarters.
Acadian Asset Management's Entasis Therapeutics Holdings Inc. position peaked at $120K in Q4 2021.
22 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q1 2022.

Based on Acadian Asset Management's 13F filing for Q1 2022, filed 12 May 2022.